Hanging in the balance

Boyd, Stephanie
December 2004
New Internationalist;Dec2004, Issue 374, p20
Focuses on the effects of various trade agreements on the availability of antiretroviral drugs in Peru. Establishment of intellectual property rules; Affordability on the costs of the pharmaceutical products; Efforts of the HIV patients to demand for free generic drugs to the government.


Related Articles

  • Antiretroviral prices too high, inconsistent, says study.  // PharmacoEconomics & Outcomes News;8/27/2005, Issue 485, p9 

    Discusses research being done on the cost of antiretrovirals in the U.S. Reference to a study by F. Pascual and colleagues, presented at the 3rd International AIDS Society Conference on HIV Pathogenesis and Treatment on July 2005; Price range of antiretrovirals per patient.

  • Factors influencing global antiretroviral procurement prices. Wirtz, Veronika J.; Forsythe, Steven; Valencia-Mendoza, Atanacio; Bautista-Arredondo, Sergio // BMC Public Health;2009 Supplement 1, Vol. 9, Special section p1 

    Background: Antiretroviral medicines (ARVs) are one of the most costly parts of HIV/AIDS treatment. Many countries are struggling to provide universal access to ARVs for all people living with HIV and AIDS. Although substantial price reductions of ARVs have occurred, especially between 2002 and...

  • Cheaper drugs for HIV patients in developing countries.  // PharmacoEconomics & Outcomes News;8/22/2009, Issue 585, p10 

    The article reports on the agreements announced by former U.S. president Bill Clinton which would enable affordable drugs for HIV patients in developing countries. The first agreement covers four antiretrovirals from Mylan and Matrix. The cost of the antiretrovirals will be reduced. The second...

  • Combination antiretroviral therapy may prove most beneficial by maintaining higher CD4 counts. Blazek, Nicole; DiMarcantonio, Tina; Haigh, Christen; Volansky, Rob // Infectious Disease News;Dec2009, Vol. 22 Issue 12, p23 

    The article discusses research on the incidence rates of seven specific cancers in patients with HIV infection treated with combination antiretroviral therapy.

  • Antiretroviral adherence swings treatment costs in Africa.  // PharmacoEconomics & Outcomes News;2/20/2010, Issue 597, p6 

    The article discusses research by J. B. Nachega et al published in the January 5, 2010 issue of the "Annals of Internal Medicine" that showed an inverse relation between adherence to antiretroviral therapy and direct healthcare cost in HIV-infected adults in South Africa.

  • HIV-positive people on ART have the same mortality risk to HIV-negative people.  // HIV Australia;2013, Vol. 11 Issue 2, p5 

    The article presents information on a report according to which HIV-positive persons responding well to antiretroviral therapy have no higher mortality risk as compared to their HIV-negative peers.

  • Uptake of antiretrovirals suboptimal in Uganda.  // PharmacoEconomics & Outcomes News;3/1/2013, Issue 673, p8 

    The article discusses research being done on the failure to initiate antiretroviral therapy among HIV-infected patients in Uganda, which references a study by E. H. Geng and colleagues published in the February 20, 2013 issue of "JAIDS."

  • Editorial Commentary: Addressing Disparities in HIV Mortality: Antiretroviral Therapy Is Necessary but Not Sufficient. Smith, Kimberly Y. // Clinical Infectious Diseases;Jun2013, Vol. 56 Issue 12, p1810 

    An introduction is presented in which the editor discusses the study which examines the influence of geographic origin and race/ethnicity on HIV mortality in patients on antiretroviral therapy (ART) in Canada, Europe, and the U.S.

  • Early initiation of ART may significantly improve HIV survival rates. Volansky, Rob // Infectious Disease News;Jun2009, Vol. 22 Issue 6, p6 

    The article focuses on a study which examined the influence of early initiation of antiretroviral therapy (ART) on the survival of human immunodeficiency virus (HIV)-positive patients.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics